Zhao Sheng Law Firm operates jointly with Linklaters LLP and boasts a particularly strong international client list, including Bayer, Intel, and Nestle. The antitrust and foreign investment practice also has an impressive domestic client base, notably acting as an advisor to SAMR and its local offices in rulemaking and enforcement matters. The practice is co-headed by Fay Zhou, Xi Liao, and Arthur Peng, all three of whom are based in Beijing. Zhou, ‘an exceptional leader’, and Peng, ’highly skilled at understanding client needs and delivering effective, timely solutions’, recently assisted Microsoft in gaining unconditional clearance from SAMR for its proposed acquisition of Activision Blizzard. Liao’s experience includes acting for Rio Tinto in obtaining its Chinese merger clearance for a joint venture with a Chinese group and other investors.
Testimonials
Collated independently by Legal 500 research team.
- ‘Zhao Sheng's antitrust team is highly knowledgeable in the life sciences and healthcare industries, providing practical and innovative advice that aligns with business needs.’
- ‘Fay Zhou is an exceptional leader, offering extensive experience in compliance and legal matters in life sciences while delivering result-oriented, actionable solutions.’
Key clients
- Ams
- AstraZeneca
Work highlights
- Assisted Microsoft with obtaining an unconditional clearance in China for its US$70bn proposed acquisition of Activision Blizzard.
- Advised Intel on China regulatory aspects of its proposed US$5.4bn acquisition of Tower Semiconductors.